FDA Adverse Event Injury Summary report: N

PFC*SIGMA C/R NPOR FEM LT SZ5

MDR report key: 3973486 · Received August 1, 2014

Report

Report Number
1818910-2014-24799
Event Type
Injury
Date Received
August 1, 2014
Date of Event
July 15, 2014
Report Date
July 15, 2014
Manufacturer
DEPUY-RAYNHAM, A DIV. OF DEPUY ORTHOPAEDICS 121965
Product Code
JWH
PMA / PMN Number
PK943462
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

EXAMINATION OF THE SUBMITTED FEMORAL DID NOT REVEAL EVIDENCE CONFIRMING DEVICE LOOSENING. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. NO INFORMATION WAS RECEIVED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS LOOSENING OF THE FEMORAL COMPONENT AT THE CEMENT/IMPLANT INTERFACE. DEPUY CEMENT WAS USED AT THE TIME OF ORIGINAL IMPLANTATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
450642 PFC*SIGMA C/R NPOR FEM LT SZ5 KNEE FEMORAL COMPONENT JWH DEPUY-RAYNHAM, A DIV. OF DEPUY ORTHOPAEDICS 121965 149414

Patients

Seq Age Sex Outcome Treatment
1 64 YR Required Intervention